DK1718337T3 - Nye kombinationer af en 5-HT3 receptorantagonist med racecadotril eller dexecadotril - Google Patents

Nye kombinationer af en 5-HT3 receptorantagonist med racecadotril eller dexecadotril

Info

Publication number
DK1718337T3
DK1718337T3 DK05702484.6T DK05702484T DK1718337T3 DK 1718337 T3 DK1718337 T3 DK 1718337T3 DK 05702484 T DK05702484 T DK 05702484T DK 1718337 T3 DK1718337 T3 DK 1718337T3
Authority
DK
Denmark
Prior art keywords
dexecadotril
racecadotril
receptor antagonist
new combinations
combinations
Prior art date
Application number
DK05702484.6T
Other languages
English (en)
Inventor
Jean-Charles Schwartz
Jeanne-Marie Lecomte
Original Assignee
Bioprojet Soc Civ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34684783&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1718337(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioprojet Soc Civ filed Critical Bioprojet Soc Civ
Application granted granted Critical
Publication of DK1718337T3 publication Critical patent/DK1718337T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
DK05702484.6T 2004-02-12 2005-02-14 Nye kombinationer af en 5-HT3 receptorantagonist med racecadotril eller dexecadotril DK1718337T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04290384A EP1563848A1 (en) 2004-02-12 2004-02-12 New combinations of an anti-emetic agent and an enkephalinase inhibitor
PCT/IB2005/000351 WO2005079850A1 (en) 2004-02-12 2005-02-14 New combinations of an anti emetic agent and an enkephalinase inhibitor

Publications (1)

Publication Number Publication Date
DK1718337T3 true DK1718337T3 (da) 2010-07-26

Family

ID=34684783

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05702484.6T DK1718337T3 (da) 2004-02-12 2005-02-14 Nye kombinationer af en 5-HT3 receptorantagonist med racecadotril eller dexecadotril

Country Status (28)

Country Link
US (1) US8222294B2 (da)
EP (2) EP1563848A1 (da)
JP (1) JP4987487B2 (da)
KR (1) KR101152308B1 (da)
CN (1) CN1917903B (da)
AT (1) ATE468138T1 (da)
AU (1) AU2005215262B2 (da)
BR (1) BRPI0506631B8 (da)
CA (1) CA2553827C (da)
CY (1) CY1110202T1 (da)
DE (1) DE602005021317D1 (da)
DK (1) DK1718337T3 (da)
EA (1) EA010625B1 (da)
EC (1) ECSP066758A (da)
ES (1) ES2344909T3 (da)
HR (1) HRP20100363T1 (da)
MA (1) MA28354A1 (da)
ME (1) ME01175B (da)
NO (1) NO337320B1 (da)
NZ (1) NZ548635A (da)
PL (1) PL1718337T3 (da)
PT (1) PT1718337E (da)
RS (1) RS51329B (da)
SI (1) SI1718337T1 (da)
TN (1) TNSN06246A1 (da)
UA (1) UA88156C2 (da)
WO (1) WO2005079850A1 (da)
ZA (1) ZA200605872B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2900823B1 (fr) * 2006-05-15 2009-02-13 Bioprojet Soc Civ Ile Nouvelle forme d'administration du racecadotril.
EP2462922A1 (en) * 2010-12-10 2012-06-13 Bioprojet New form of administration of enkephalinase inhibitor
NZ702930A (en) * 2012-06-28 2017-05-26 Mcneil-Ppc Inc Racecadotril liquid compositions
US9114171B2 (en) * 2012-06-28 2015-08-25 Mcneil-Ppc, Inc. Racecadotril liquid compositions
MX2015000217A (es) 2012-06-28 2015-04-10 Mcneil Ppc Inc Composiciones lipidicas de racecadotrilo.
US9801819B2 (en) * 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
MA40859A (fr) 2014-10-29 2017-09-05 Johnson & Johnson Consumer Inc Particules de cadotril

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins

Also Published As

Publication number Publication date
ZA200605872B (en) 2008-01-08
ECSP066758A (es) 2006-11-24
BRPI0506631B8 (pt) 2021-05-25
CN1917903B (zh) 2010-07-21
EA010625B1 (ru) 2008-10-30
MA28354A1 (fr) 2006-12-01
KR20060132691A (ko) 2006-12-21
WO2005079850A1 (en) 2005-09-01
NZ548635A (en) 2009-10-30
PT1718337E (pt) 2010-06-16
RS51329B (en) 2011-02-28
CA2553827A1 (en) 2005-09-01
AU2005215262B2 (en) 2011-03-03
PL1718337T3 (pl) 2010-09-30
BRPI0506631B1 (pt) 2018-12-04
AU2005215262A1 (en) 2005-09-01
ES2344909T3 (es) 2010-09-09
CN1917903A (zh) 2007-02-21
DE602005021317D1 (de) 2010-07-01
SI1718337T1 (sl) 2010-08-31
BRPI0506631A (pt) 2007-05-08
CY1110202T1 (el) 2015-01-14
ME01175B (me) 2013-03-20
JP2007522202A (ja) 2007-08-09
JP4987487B2 (ja) 2012-07-25
KR101152308B1 (ko) 2012-06-11
EP1718337B1 (en) 2010-05-19
EA200601466A1 (ru) 2006-12-29
ATE468138T1 (de) 2010-06-15
US20070275993A1 (en) 2007-11-29
EP1563848A1 (en) 2005-08-17
EP1718337A1 (en) 2006-11-08
US8222294B2 (en) 2012-07-17
NO337320B1 (no) 2016-03-07
CA2553827C (en) 2012-08-07
HRP20100363T1 (hr) 2010-07-31
UA88156C2 (ru) 2009-09-25
TNSN06246A1 (fr) 2007-12-03
NO20063973L (no) 2006-09-05

Similar Documents

Publication Publication Date Title
DK1718337T3 (da) Nye kombinationer af en 5-HT3 receptorantagonist med racecadotril eller dexecadotril
MA52942A (fr) Composés inhibiteurs d'oga
MA52939A (fr) Composés inhibiteurs d'oga
ATE479687T1 (de) Kinaseinhibitoren
DK1912636T3 (da) N-(arylamino)-sulfonamid-inhibitorer af mek
DK1836201T4 (da) Pyrrolidininhibitorer af IAP.
DK1765953T3 (da) Kølemiddelsammensætning
MA54399A (fr) Radioimmunoconjugués et polythérapie à base d'inhibiteur de point de contrôle
NO20070211L (no) Kationiske polymerer som inneholder 2-hydroksyetyl-metakrylsyre som akseleratorer for ASA-liming
EA200970407A1 (ru) Ингибиторы киназ mapk/erk
ATE423765T1 (de) Ep2-rezeptoragonisten
DK1906972T3 (da) LPA2-receptoragonist til behandling af diarré
CO2019001046A2 (es) Mancha blanca
MA52937A (fr) Composés inhibiteurs d'oga
MA52935A (fr) Composés inhibiteurs d'oga
MA52936A (fr) Composés inhibiteurs d'oga
DK3858725T3 (da) Skroghjælpemekanisme til reduktion af dybgangen af et skrog
MA52938A (fr) Composés inhibiteurs d'oga
AR066010A1 (es) 4-(3- aminobenzoil)-1,3- dimetilpirazoles y su utilizacion como herbicidas
BE1028574B1 (nl) Heterocyclische verbindingen gebruikt als nitrificatieremmer
UA40125S (uk) Молоток покрівельника
MA52933A (fr) Composés inhibiteurs d'oga
UA39746S (uk) Логотип «фабрика тишины»
MA56098A (fr) Immunomodulateurs hétérocycliques utilisés comme inhibiteur de point de contrôle pdl1
MA52072A (fr) Inhibiteurs d'oxazine monoacylglycerol lipase (magl)